Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...
Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
A research team led by Prof. ZENG Zhutian from the University of Science and Technology of China (USTC) identified and named a novel population of bladder-resident macrophages, termed suburothelial ...
Little is known about how the immune system prevents vesicular stomatitis virus (VSV) from entering the central nervous system (CNS) following infection through the natural subcutaneous route.
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...
SPP1+ Macrophages Identified as Key Drivers and Therapeutic Targets In Colorectal Cancer Progression
Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related deaths worldwide.
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback